AIDS Vaccine

African program needs $233 million, WHO says

Published in Medical Letter on the CDC and FDA, July 28th, 2002

African scientists, multilateral and donor organizations, research agencies and industry met in Cape Town in June 2002, to accelerate research and testing for the development of an AIDS vaccine for Africa. The meeting aimed to define a plan of action for the next 7 years, and to raise US$233 million for the African AIDS Vaccine Programme (AAVP).

Two-thirds of all people living with HIV are in Africa. African vaccine research currently receives only $41 million of the $2.5 billion - that is, 1.6% - spent on HIV research annually.

Although more than 30 HIV vaccine trials have been conducted globally since 1987, only two of these were carried out in...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2002-07-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry